A Rapidly Changing Healthcare Landscape
Medical original equipment manufacturers (OEMs) are at the forefront of the global effort to empower consumers and their physicians to be more proactive in diagnosing the risk or onset of chronic disease to improve treatment outcomes and lower costs. This effort represents nothing less than the transformation of the world’s healthcare systems.
Chronic diseases — conditions such as cancer, heart disease, type 2 diabetes and Alzheimer’s that require ongoing medical attention or limit activities of daily living for a year or longer — are the leading causes of rising healthcare costs worldwide1.
Across the globe, medical OEMs are developing innovative products that make it easier and less costly for people to collect, analyze and share their health data in real-time with their doctors and, in turn, for primary care physicians to collaborate with specialists worldwide. They’re capitalizing on innovations in multiple technologies including Big Data analytics, AI, machine learning, the rollout of 5G networks, and the maturation of the hyperscale data center and edge computing. This will ultimately create the products that will serve as the foundation of this next generation of patient care.
Consider the rapid changes in healthcare delivery following the onset of the COVID-19 pandemic that forced doctors to use telemedicine platforms to conduct virtual examinations. Beyond the virtual examination room, technologies like remote-operated robotic surgical tools enable surgeons to perform once-risky procedures with incredible precision and less invasively to reduce risk and improve patient outcomes.
"We need to rapidly step up prevention, diagnosis and treatment of noncommunicable diseases. They highlight the urgency of drastically improving primary health care equitably and holistically."
Dr. Tedros Adhanom Ghebreyesus, Director General of the World Health Organization2
It's an Exciting Time For Medical OEMS.
They have the opportunity to produce products that grow their businesses, and contribute to the realization of the industry’s goals of reducing global healthcare costs and deliver high quality care to more people.
As medical OEMs innovate and build their products, it is important to consider the complete product lifecycle. The upfront design needs to be robust to help minimize risk in later product life that may impact patient experience.
This white paper explains how a medical OEM, whether a new startup or a large multinational corporation, can seize this opportunity to manage potential risk by addressing four key considerations early in the design process.
Design for Manufacturability
Design for Supply Chain
Design for Quality Process Failure Mode and Effects Analysis
Design for Quality Device History Record
"Conducting a comprehensive DFx early in the design process and before production begins will reduce risk, lower costs, ensure the highest level of quality and improve speed to market.
These initial steps will also ensure a new product’s long-term manufacturability and sustainability as you increase production volumes when entering new markets and expanding your customer base worldwide."
Kevin Walsh, Vice President, HealthTech, Celestica